We are live on ! Find out more
Jacobs Levy Equity Management

Jacobs Levy Equity Management Portfolio holdings

AUM $27.8B Turnover 30.15%
1-Year Est. Return 46.46%
 

Jacobs Levy Equity Management manages U.S. stock portfolios, and its owners Bruce Jacobs and Ken Levy pioneered a research method called disentangling. The firm was founded in 1986, and Jacobs and Levy spent more than three years studying market inefficiencies in U.S. stocks before taking on client money in 1990. Disentangling examines many factors that move stock prices at once, to isolate the separate effect of each, and the firm blends it with behavioral finance theory and human judgment. It runs long-only and long/short portfolios across large and small companies, including versions that hold about 130% or 150% of capital in long positions and 30% or 50% in short ones. Its clients are institutions such as pension plans, endowments, foundations and sovereign wealth funds.

This Fund
S&P 500
This Quarter Est. Return
+31.84%
1 Year Est. Return
+46.46%
3 Year Est. Return
+129.16%
5 Year Est. Return
+174.16%
10 Year Est. Return
+698%
AUM
$27.8B
AUM Growth
+$4.02B
Cap. Flow
-$324M
Cap. Flow %
-1.17%
Top 10 Hldgs %
27.66%
Holding
1,111
New
158
Increased
319
Reduced
438
Closed
177
Avg Time Held
2.1 years
Top 10 Avg Time Held
4.2 years
Top 20 Avg Time Held
2.4 years

Top Buys

Rank Stock Value
1
KLAC icon
KLA
KLAC
+$325M
2
CRWD icon
CrowdStrike
CRWD
+$225M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$186M
4
SNDK icon
Sandisk
SNDK
+$155M
5
SYY icon
Sysco
SYY
+$147M

Top Sells

Rank Stock Value
1
QCOM icon
Qualcomm
QCOM
+$418M
2
NOW icon
ServiceNow
NOW
+$262M
3
AAPL icon
Apple
AAPL
+$260M
4
MAS icon
Masco
MAS
+$163M
5
ROKU icon
Roku
ROKU
+$139M

Sector Composition

Rank Sector Weight
1 Technology 33.14%
2 Financials 13.01%
3 Consumer Discretionary 12.82%
4 Industrials 11.2%
5 Healthcare 10.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
BIOA icon
326
BioAge Labs
BIOA
$255M
$9.24M 0.03%
377,085
-43,038
-10% -$778K
2025 Q2
4 quarters
STRT icon
327
STRATTEC Security
STRT
$250M
$9.18M 0.03%
112,723
+21,099
+23% +$1.6M
2025 Q3
3 quarters
FTRE icon
328
Fortrea Holdings
FTRE
$1.95B
$9.17M 0.03%
526,897
+28,154
+6% +$380K
2026 Q1
1 quarter
COCO icon
329
Vita Coco
COCO
$3.6B
$9.16M 0.03%
138,550
-216,764
-61% -$14.6M
2025 Q2
4 quarters
TIGO icon
330
Millicom
TIGO
$13.3B
$9.04M 0.03%
99,626
-16,303
-14% -$1.37M
2026 Q1
1 quarter
TNK icon
331
Teekay Tankers
TNK
$3.1B
$9M 0.03%
138,793
-13,736
-9% -$1.03M
2022 Q3
15 quarters
CVCO icon
332
Cavco Industries
CVCO
$4.92B
$8.97M 0.03%
14,595
+2,757
+23% +$1.46M
2022 Q3
15 quarters
SFIX icon
333
Stitch Fix
SFIX
$379M
$8.95M 0.03%
2,177,945
-55,463
-2% -$202K
2024 Q3
7 quarters
NRIX icon
334
Nurix Therapeutics
NRIX
$1.69B
$8.82M 0.03%
363,603
-257,217
-41% -$4.38M
2025 Q3
3 quarters
WDFC icon
335
WD-40
WDFC
$2.99B
$8.82M 0.03%
36,186
-31,684
-47% -$6.78M
2025 Q1
5 quarters
HRTG icon
336
Heritage Insurance Holdings
HRTG
$998M
$8.81M 0.03%
337,778
-20,904
-6% -$521K
2024 Q4
6 quarters
AGNT icon
337
AGNT Inc
AGNT
$466M
$8.72M 0.03%
1,611,106
+813,374
+102% +$4.48M
2024 Q2
8 quarters
EVH icon
338
Evolent Health
EVH
$554M
$8.68M 0.03%
1,601,638
+991,536
+163% +$3.8M
2025 Q2
4 quarters
WDAY icon
339
Workday
WDAY
$47.3B
$8.66M 0.03%
70,772
-283,141
-80% -$35.9M
2025 Q3
3 quarters
ETD icon
340
Ethan Allen Interiors
ETD
$441M
$8.63M 0.03%
386,299
-17,846
-4% -$378K
2025 Q1
5 quarters
DXPE icon
341
DXP Enterprises
DXPE
$2.38B
$8.62M 0.03%
51,057
+44,970
+739% +$7.09M
2025 Q4
2 quarters
ASTH icon
342
Astrana Health
ASTH
$1.58B
$8.58M 0.03%
184,901
-201,523
-52% -$7.25M
2024 Q3
7 quarters
SDGR icon
343
Schrodinger
SDGR
$2.22B
$8.51M 0.03%
+523,675
New +$7.01M
2026 Q2
0 quarters
MMI icon
344
Marcus & Millichap
MMI
$936M
$8.5M 0.03%
272,747
+113,128
+71% +$3.24M
2025 Q4
2 quarters
PLTK icon
345
Playtika
PLTK
$1.01B
$8.38M 0.03%
2,253,890
+766,603
+52% +$2.65M
2022 Q3
15 quarters
CTRN icon
346
Citi Trends
CTRN
$364M
$8.27M 0.03%
143,034
+20,208
+16% +$969K
2025 Q3
3 quarters
DSGN icon
347
Design Therapeutics
DSGN
$670M
$8.18M 0.03%
565,597
+276,212
+95% +$3.44M
2025 Q4
2 quarters
SMTC icon
348
Semtech
SMTC
$10.7B
$8.08M 0.03%
+49,936
New +$6.53M
2026 Q2
0 quarters
BLMN icon
349
Bloomin' Brands
BLMN
$889M
$7.98M 0.03%
873,618
+323,032
+59% +$2.35M
2026 Q1
1 quarter
FELE icon
350
Franklin Electric
FELE
$4.34B
$7.87M 0.03%
73,388
-3,282
-4% -$330K
2025 Q1
5 quarters

Similar funds

Jacobs Levy Equity Management's Q2 2026 Portfolio in Review

As of Q2 2026, Jacobs Levy Equity Management held 1,111 positions worth $27.8B, up 17% from $23.8B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Jacobs Levy Equity Management's Q2 2026 filing shows 158 new, 319 increased, 438 reduced and 177 closed positions. Its largest new stake was Sysco: 1,938,184 shares worth $162M. The largest sale was Qualcomm, an estimated $418M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 31% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Jacobs Levy Equity Management's largest Q2 2026 buy was Sysco: 1,938,184 shares worth $162M.
  • Jacobs Levy Equity Management added most to KLA in Q2 2026, an estimated $325M increase.
  • Jacobs Levy Equity Management's biggest Q2 2026 reduction was Qualcomm, cutting an estimated $418M.
  • Jacobs Levy Equity Management fully exited Roku in Q2 2026, selling an estimated $139M.
  • Jacobs Levy Equity Management's ten largest holdings make up 28% of its $27.8B portfolio in Q2 2026.
  • Jacobs Levy Equity Management opened 158 new positions and closed 177 in Q2 2026.
  • Jacobs Levy Equity Management's portfolio value rose 17% quarter-over-quarter to $27.8B.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2026, filed 14 Aug 2026.